• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Dr. Jack Vaisman, Advanced Medical Institute Inc. Founder, CEO, President and Chairman of the Board, Awarded Innovation Patent By Australian Patent Office

Posted on: Monday, 15 August 2005, 12:01 CDT

It was announced today that Dr. Jack Vaisman, Chief Executive Officer, President and Chairman of the Board of Directors of Advanced Medical Institute Inc. (Pink Sheets:AVMD), a leading provider of treatment for erectile dysfunction (ED) and premature ejaculation (PE) treatment in Australia, has been awarded an Innovation Patent by the Commonwealth of Australia Patent Office. The patent, titled Treatment of Premature Ejaculation, relates to various methods of treatment delivery via nasal (mucosal) inhalation and topical application of certain formulations which are used in AVMD.PK's treatment programs for premature ejaculation. These formulations have previously been used to treat PE and other medical conditions.

"I am very pleased that the Australian Patent Office has recognized our innovative work in the treatment of premature ejaculation," stated Dr. Vaisman. "We are continuing to focus much of our R&D budget and attention on developing new treatment methods and delivery systems for the treatment of PE and ED. We anticipate that the development of these methods will allow us to substantially reduce the amount of medication required for treatment, as the dosage levels which are clinically effective through our delivery systems are much lower than those used by any of our competitors in the treatment of PE and ED and as patients may no longer need to use these medications chronically. These systems will also enable many patients, unable to use standard treatment methods such as oral intake, to be successfully treated for PE and ED," he added. Dr. Vaisman is in the process of formally licensing the rights of use of the new patent to AVMD.

About the Company

Advanced Medical Institute Inc. (Pink Sheets:AVMD), headquartered in Sydney, Australia, is a leading provider of treatment programs for erectile dysfunction and premature ejaculation in Australia. The company operates 22 treatment clinics in Australia, has more than 130 employees, including 25 medical personnel, and since its inception has provided treatment to more than 250,000 patients. Advanced Medical Institute and its predecessor company began treating PE and ED patients successfully in 1993, 6 years prior to the launch of Viagra, in 1999, in Australia.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations or beliefs, including, but not limited to, statements concerning the company's operations and financial performance and condition. For this purpose, statements that are not statements of historical fact may be deemed to be forward-looking statements. The company cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the impact of competitive products and pricing; changes in consumer preferences and tastes or perceptions of health-related issues; effectiveness of advertising or market-spending programs; changes in laws and regulations; fluctuations in costs of production, foreign exchange and interest rates; and other factors as those discussed in the company's reports filed with the Securities and Exchange Commission from time to time.

Source: Business Wire

More News in this Category